Zensar Technologies Limited CC-Mar25.pdf · 2025-04-25
Yes.
Sandeep, first of all, thank you for the kind words on the results. See, as far as the macro is concerned, I mean, you would have heard from others also. So, there is the first order effect, which is likely to impact much more on manufacturing rather than consumer services. And fortunately, or unfortunately, our exposure to manufacturing and automotive is fairly limited. While for retail, it is slightly more. Of the 27%, I would say, majority is retail. So, we don't expect to be impacted as much. Healthcare and Life Sciences, again, I don't think there will be a significant downshift from a pricing from overall perspective, primarily because these are relatively price inelastic. I mean a person who has to get a shot has to get a shot irrespective of whether it costs $10 or $15. As far as the overall thing is concerned, I would say our order book is going to take us through first quarter or second quarter max of this year. And in fact, towards the end of the previous quarter, we started seeing some rightward shift of demand, not really cancellations, but rightward shift of demand. So from a demand perspective, I wouldn't say I'm concerned, but I would say that there is a lot of uncertainty, and it is the uncertainty that is concern.